Korro Bio (KRRO) Assets Growth (3y) (2021 - 2026)

Korro Bio (KRRO) Assets Growth (3y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Korro Bio 123.70 Mn 9.73 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 21.85%
Dec 31, 2025 15.46%
Sep 30, 2025 5.90%
Jun 30, 2025 6.43%
Mar 31, 2025 7.03%
Dec 31, 2024 6.87%
Sep 30, 2024 6.40%
Jun 30, 2024 4.26%
Mar 31, 2024 -6.41%
Dec 31, 2023 -5.75%
Sep 30, 2023 -41.73%
Jun 30, 2023 -27.09%
Mar 31, 2023 -22.22%
Dec 31, 2022 -30.87%
Sep 30, 2022 -7.32%
Dec 31, 2021 60.84%